Clinical Trial

Turkish Validation of the Rapprich Lipedema Symptomatic Assessment Questionnaire

Study acronym: RapprichTR
Recruiting
View on ClinicalTrials.gov →
Summary
Lipedema is a chronic disease characterized by abnormal fat accumulation, primarily in the lower extremities, affecting women. This study aims to evaluate the validity and reliability of the Turkish version of the Rapprich Lipedema Symptomatic Assessment Questionnaire, which was originally developed by Rapprich et al. in 2010. Since a validated Turkish version is currently unavailable, this research will provide a standardized tool for clinicians to assess symptomatic severity in Turkish-speaking lipedema patients.
Trial Details
NCT Number NCT07725146
Lead Sponsor Marmara University
Conditions Lipedema
Enrollment 180 participants
Start Date 2026-07-17
Primary Completion 2027-02-15 (estimated)
Study Completion 2027-03-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-24